Hematology
Work with the experts in the design, conduct and management of hematology trials—from early phase to registrational and post approval.
Drayton Virkler
President and Chief Commercial Officer
Drayton Virkler is President and Chief Commercial Officer at Fortrea, focused on improving the probability of success of biopharmaceutical companies across the globe as they bring life-saving and life-enhancing products to the market. Drayton joined the organization in May 2023 during Fortrea’s spinoff from its parent company, Labcorp.
Drayton has a broad array of global and industrial experience including leadership of global go-to-market teams as well as leadership of global and regional business development teams in the U.S., Canada and Asia Pacific. He spent the last 20 years working in the life sciences sector across service providers and pharmaceutical sponsors. Before joining Fortrea, Drayton was the President of the Regulatory and Access division at Certara, a global leader in biosimulation, technology and tech-driven services to accelerate medicine development for biopharmaceutical companies. Previously, he served as Certara’s Chief Commercial Officer. Drayton held a variety of commercial leadership roles at Quintiles, now part of IQVIA, a human data science company. During his 10-year tenure, he led business development in the US and Canada and led its Asia Pacific business development team. Drayton served as head of Investor Relations for Talecris Biotherapeutics, building and managing the function after the company’s $1 billion IPO in 2009 and through its acquisition by Grifols in 2011. Prior to joining Talecris in 2008, Drayton was an executive with GSK from 2003 to 2008 where he held a variety of positions in marketing and sales. Earlier in his career, Drayton worked as a country manager and formulation chemist for his family's textile chemical company. He has lived and worked in Argentina, Mexico, Singapore and the U.S., and is fluent in English and Spanish.
Drayton has a bachelor’s degree in chemistry from Washington and Lee University and an MBA from Duke University's Fuqua School of Business. He serves on the International Board of Directors for the Juvenile Diabetes Research Foundation (JDRF) as well as the Board of Visitors for the Fuqua School of Business.
David Cooper
Chief Administrative Officer
David Cooper has served as Fortrea’s Chief Administrative Officer since May 2023, responsible for Human Resources, Procurement, Facilities and Corporate Communications.
Dave has almost 30 years of leadership experience in the hospital and health care industry. Before transitioning to his Fortrea role, he served as the Vice President of Global People Experience at Labcorp, a global Fortune 500 healthcare services firm. Prior to Labcorp, Dave was the Chief Human Resources officer at Q2 Solutions, an independent provider of global drug development services following a spinoff from Quintiles. Previously, he served for more than a decade in a variety of leadership roles at Quintiles, a publicly traded healthcare services company. Earlier in his career, he worked in staffing-focused roles at Solectron, now part of Flextronics, and Govig & Associates.
He earned his bachelor's degree in Management from the Georgia Institute of Technology.
Work with the experts in the design, conduct and management of hematology trials—from early phase to registrational and post approval.
Our endocrinology professionals leverage their extensive diabetes and lipid disorder experience to help you create streamlined solutions. Learn more here.
Discover Fortrea's research efforts in autoimmune diseases, focusing on developing effective treatments and improving patient care.
Fortrea's cutting-edge scientific and medical experts leverage global outreach to provide patient-centric clinical trials, astute counsel and enterprise-wide centers of excellence that yield true value in the form of transformative insights and applied market impact for dermatology studies.
Discover how our therapeutic insights help deliver your life-changing solutions faster.
Fortrea has over 30 years of worldwide experience in the late phase industry. We have deep institutional expertise across all therapeutic areas, established investigator relationships and broad real-world insights. Learn more here.
Fortrea offers in vitro diagnostic development and lab test solutions. Partner with us for advanced diagnostic testing and innovative lab development services.
Our specialized medical device division within our global CRO offers consultation and support, providing essential insights and expertise to help you maximize your device’s potential.